Does Alto Neuroscience Inc (ANRO)’s Current Price Volatility Hinder Its Future Potential?
Alto Neuroscience Inc (NYSE:ANRO) has a beta value of 1.90 and has seen 0.86 million shares traded in the recent trading session. The company, currently
Alto Neuroscience Inc (NYSE:ANRO) has a beta value of 1.90 and has seen 0.86 million shares traded in the recent trading session. The company, currently
Americold Realty Trust Inc (NYSE:COLD) has a beta value of 0.85 and has seen 1.01 million shares traded in the recent trading session. The company,
Crescent Energy Co (NYSE:CRGY) has a beta value of 1.24 and has seen 1.08 million shares traded in the recent trading session. The company, currently
SpringWorks Therapeutics Inc (NASDAQ:SWTX) has a beta value of 0.70 and has seen 2.03 million shares traded in the recent trading session. The company, currently
Full Truck Alliance Co Ltd ADR (NYSE:YMM) has a beta value of 0.20 and has seen 1.45 million shares traded in the recent trading session.
Clarivate Plc (NYSE:CLVT) has a beta value of 1.48 and has seen 0.93 million shares traded in the recent trading session. The company, currently valued
Matinas Biopharma Holdings Inc (AMEX:MTNB) has a beta value of 1.29 and has seen 2.99 million shares traded in the recent trading session. The MTNB
Incyte Corp (NASDAQ:INCY) has a beta value of 0.67 and has seen 1.64 million shares traded in the recent trading session. The company, currently valued
Ultrapar Participacoes S.A. ADR (NYSE:UGP) has a beta value of 1.04 and has seen 0.98 million shares traded in the recent trading session. The company,
Turnstone Biologics Corp (NASDAQ:TSBX) has a beta value of 1.18 and has seen 8.52 million shares traded in the recent trading session. The company, currently
© 2024, Powered by Smart TechOne